Impaired glucose tolerance and mild diabetes induce β-cell dysfunction in mice

Area of Science:

• Endocrinology
• Metabolic Research
• Diabetes Pathophysiology

Background:

• Type 2 diabetes is preceded by years of impaired beta-cell function and glucose tolerance.
• Severe hyperglycemia (>15 mM) impairs beta-cell metabolism and insulin secretion.
• The impact of mild hyperglycemia and impaired glucose tolerance on beta-cells is not fully understood.

Purpose of the Study:

• To investigate the detrimental effects of chronic mild hyperglycemia and impaired glucose tolerance on pancreatic beta-cells.
• To determine if subtle glycemic changes compromise beta-cell function.

Main Methods:

• Experimental induction of mild hyperglycemia (2-3 mM elevation) and impaired glucose tolerance in a model system.
• Analysis of beta-cell gene expression, metabolic enzyme activity, mitochondrial function, and insulin secretion.
• Assessment of insulin content and secretion capacity.

Main Results:

• Chronic mild hyperglycemia (2-3 mM) significantly impairs beta-cell function.
• Mild hyperglycemia alters metabolic gene expression and reduces insulin content and secretion.
• Impaired glucose tolerance also causes significant detrimental changes to beta-cells.
• Mitochondrial oxidative phosphorylation and metabolic enzyme activity were notably affected.

Conclusions:

• Altered beta-cell metabolism is an early event in type 2 diabetes development.
• Even mild hyperglycemia and impaired glucose tolerance are detrimental to beta-cell function.
• Therapeutic interventions targeting prediabetes are crucial for preventing type 2 diabetes progression.